Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04728295 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)
A NA study of Parkinson Disease, sponsored by InSightec.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 9
- Study locations
NCT04728295 is a NA study of Parkinson Disease that is active but no longer recruiting, run by InSightec. The registered enrollment target is 50 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 9 study locations across 7 states.
The verdict
NCT04728295, a NA study of Parkinson Disease, is active but no longer recruiting, sponsored by InSightec.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 9
- Study locations
Study Summary
Evaluate the Safety and Effectiveness of Staged Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD).
Conditions Studied
Interventions
- DEVICE Exablate 4000
Study Locations (9)
New York
- New York University Langone - New York
- Weill Cornell Medicine - New York
Other
- Neurology, Hospital Universitario HM Puerta del Sur (HM CINAC) - Madrid
- Clínica Universidad de Navarra - Pamplona
California
- Stanford - Palo Alto
Florida
- Delray Medical Center - Delray Beach
Illinois
- Rush University Medical Center - Chicago
Maryland
- University of Maryland, Baltimore - Baltimore
Changhua County
- Chang Bing Show Chwan Memorial Hospital - Lugang
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-05-14 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04728295
The ClinicalTrials.gov registry entry for NCT04728295 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Exablate 4000 is the first listed.
NCT04728295 reports 9 study locations spanning 7 distinct geographic areas - top geographies include New York, Other, California.
Frequently Asked Questions
What is clinical trial NCT04728295 about?
NCT04728295 is a clinical study titled "Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)". Evaluate the Safety and Effectiveness of Staged Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD).
What is the current status of trial NCT04728295?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-05-14. Estimated completion is 2028-12-01.
What conditions does trial NCT04728295 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT04728295?
The interventions under investigation include: Exablate 4000 (DEVICE).
Who is sponsoring clinical trial NCT04728295?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04728295 being conducted?
This trial has 9 study locations across California, Florida, Illinois, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Neurophysiology of Reward Signaling in Parkinson's Disease
RECRUITING · NA
-
Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease
RECRUITING · NA
-
Rock Steady Boxing: A Community Based In Person Class
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.